Quarterly report pursuant to sections 13 or 15(d)

STOCKHOLDERS EQUITY (DEFICIT) (Details Narrative)

v2.4.0.6
STOCKHOLDERS EQUITY (DEFICIT) (Details Narrative) (USD $)
2 Months Ended 3 Months Ended 6 Months Ended
Aug. 31, 2012
Mar. 31, 2012
Mar. 31, 2013
Mar. 31, 2012
Aug. 31, 2012
Mar. 08, 2013
Mar. 01, 2013
Jan. 28, 2013
Dec. 31, 2012
Dec. 27, 2012
Dec. 07, 2012
Nov. 14, 2012
Jun. 11, 2012
Jan. 26, 2012
Nov. 25, 2011
Decimal
Equity [Abstract]                              
Forward Split                             1.362612612
Stock dividend granted                             0.362612612
Increased number of authorized capital common stock     200,000,000           200,000,000   200,000,000        
Authorized capital, common stock par value per share     $ 0.0001           $ 0.0001   $ 0.0001       $ 0.0001
Original number of authorized capital common stock                     75,000,000        
Preferred stock, shares authorized     50,000,000           50,000,000   50,000,000        
Preferred stock, par value     $ 0.0001           $ 0.0001   $ 0.0001        
Capital stock exchanged for common stock                     10,000,000     10,000,000  
Ten-year warrants to purchase shares of common stock   2,700,000   2,700,000                   6,000,000  
Ten-year warrant issued, exercise price per share   $ 0.50 $ 0.57 $ 0.50                   $ 0.50  
Post-split shares cancelled                           4,769,144  
Post-split shares remaining, identified as float                           7,500,000  
Shares sold for cash                   1,870,000       10,029,965  
Share Price                           $ 0.50  
Proceeds from sale of shares                   $ 743,000       $ 4,993,965  
Issuance of common stock for advances payable                           100,000  
Proceeds allocated to Amicor for working capital, shares                           200,000  
Debt owned for legal fees incurred by Amicor                           75,000  
Proceeds allocated to Amicor for legal fees, gross                           300,000  
Proceeds allocated to Amicor for legal fees, net                           5,293,965  
Proceeds allocated to Amicor for legal fees, shares                           600,000  
Legal Fees paid in private placement                           21,000  
Option to acquire rights and properties held by Pershing                           10  
Ownership Interest of Pershing in Company                           26.65%  
Payment on note payable - related party                           1,000,000  
Sold common stock in private placement   1,300,000                          
Sold common stock in private placement, purchase price per share                           $ 0.50  
Net proceeds from sale of common stock   650,000                          
Principal amount of note, paid                 930,000            
Total balance of private placement                 1,000,000            
Final payment of note, not required                 70,000            
Total balance of private placement, paid                 930,000            
Recorded shares                 10,000,000            
Recorded shares at par value                 1,000            
Common stock issued on cashless basis, shares         4,494,829                    
Common stock warrants issued on cashless basis, shares         6,200,000                    
Cancelled shares of common stock                         9,806,667    
Cancelled warrants in connection with Rescission Agreement                         4,800,000    
Additional paid in capital to Amicor Shareholders                         132,000    
Exchanged common stock for issued and outstanding membership interests of Sampo                       9,250,000      
Cash payment to Sampo                       500,000      
Exchanged common stock for issued and outstanding membership interests of Sampo, par value                       925      
Value of net assets                       500,925      
Sold units to accredited investors pursuant to subscription agreement                   1,089,109          
Gross proceeds to the Company                   866,287          
Sold units to accredited investors pursuant to subscription agreement, purchase price per unit                   $ 0.80          
Common stock sold for the conversion of unpaid salaries                   83,218          
Unpaid salaries                   33,287          
Common stock sold for certain outstanding amounts for legal fees                   225,000          
Total amount for common stock sold                   866,287          
Placement agency fees paid in cash to broker-dealer                   5,000          
Issued common stock in connection with the exercise of Consulting Warrants   2,722,222   2,722,222                      
Warrants valued on the grant date   6,500,000   6,500,000                      
Warrants valued on the grant date, per warrant   $ 0.50   $ 0.50                      
Total value of warrants on grant date   3,242,850   3,242,850                      
Volatility rate   191.00%   191.00%                      
Risk free interest rate 0.61% 1.96%   1.96% 0.61%                    
Stock-based compensation expense     49,197                        
Stock-based consulting expense       2,536,075                      
Total unrecognized compensation expense     144,820                        
Issued common stock two warrants holders 605,940                            
Granted 10-year options to Executives for purchase of common stock 3,000,000       3,000,000                    
Granted restricted shares to Mr. Groussman 1,000,000       1,000,000                    
Common stock options valued on grant date 3,000,000       3,000,000                    
Common stock option, per option $ 0.48       $ 0.48                    
Total value of common stock options 1,454,400       1,454,400             968,600      
Expected term 5 years       5 years                    
Unvested restricted stock grant forfeited to the Company for cancellation                       1,000,000      
Common stock purchased with fully vested option grant                       1,500,000      
Annual salary             195,000 75,000       350,000      
Common stock purchased with ten year option award               500,000       2,000,000      
Common stock purchased with ten year option award, exercise price per share           $ 0.50   $ 0.50              
Common stock purchased with five year option award           100,000 1,000,000                
Intrinsic value of stock options outstanding     $ 0